IRIS Accounts Production v24.3.0.553 SC710112 director 1.2.23 31.1.24 31.1.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC7101122023-01-31SC7101122024-01-31SC7101122023-02-012024-01-31SC7101122022-01-31SC7101122022-02-012023-01-31SC7101122023-01-31SC710112ns15:Scotland2023-02-012024-01-31SC710112ns14:PoundSterling2023-02-012024-01-31SC710112ns10:Director12023-02-012024-01-31SC710112ns10:PrivateLimitedCompanyLtd2023-02-012024-01-31SC710112ns10:SmallEntities2023-02-012024-01-31SC710112ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-31SC710112ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-31SC710112ns10:FullAccounts2023-02-012024-01-31SC710112ns10:RegisteredOffice2023-02-012024-01-31SC710112ns5:CurrentFinancialInstruments2024-01-31SC710112ns5:CurrentFinancialInstruments2023-01-31SC710112ns5:ShareCapital2024-01-31SC710112ns5:ShareCapital2023-01-31SC710112ns5:RetainedEarningsAccumulatedLosses2024-01-31SC710112ns5:RetainedEarningsAccumulatedLosses2023-01-31SC710112ns5:LeaseholdImprovements2023-02-012024-01-31SC710112ns5:PlantMachinery2023-02-012024-01-31SC710112ns5:FurnitureFittings2023-02-012024-01-31SC710112ns5:ComputerEquipment2023-02-012024-01-31SC710112ns5:LeaseholdImprovements2023-01-31SC710112ns5:PlantMachinery2023-01-31SC710112ns5:FurnitureFittings2023-01-31SC710112ns5:ComputerEquipment2023-01-31SC710112ns5:LeaseholdImprovements2024-01-31SC710112ns5:PlantMachinery2024-01-31SC710112ns5:FurnitureFittings2024-01-31SC710112ns5:ComputerEquipment2024-01-31SC710112ns5:LeaseholdImprovements2023-01-31SC710112ns5:PlantMachinery2023-01-31SC710112ns5:FurnitureFittings2023-01-31SC710112ns5:ComputerEquipment2023-01-31SC710112ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-31SC710112ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-31
REGISTERED NUMBER: SC710112 (Scotland)













Unaudited Financial Statements

for the Year Ended 31 January 2024

for

IRVINE HEALTHCARE LTD

IRVINE HEALTHCARE LTD (REGISTERED NUMBER: SC710112)






Contents of the Financial Statements
FOR THE YEAR ENDED 31 JANUARY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


IRVINE HEALTHCARE LTD

Company Information
FOR THE YEAR ENDED 31 JANUARY 2024







DIRECTOR: S Shafiq





REGISTERED OFFICE: 6th Floor
Gordon Chambers
90 Mitchell Street
Glasgow
G1 3NQ





REGISTERED NUMBER: SC710112 (Scotland)





ACCOUNTANTS: BK Plus Ltd
6th Floor
Gordon Chambers
90 Mitchell Street
Glasgow
Lanarkshire
G1 3NQ

IRVINE HEALTHCARE LTD (REGISTERED NUMBER: SC710112)

Balance Sheet
31 JANUARY 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 177,548 217,742

CURRENT ASSETS
Stocks 2,300 1,500
Debtors 5 16,826 5,127
Cash at bank 19,183 85
38,309 6,712
CREDITORS
Amounts falling due within one year 6 394,475 327,169
NET CURRENT LIABILITIES (356,166 ) (320,457 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(178,618

)

(102,715

)

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (178,718 ) (102,815 )
(178,618 ) (102,715 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

IRVINE HEALTHCARE LTD (REGISTERED NUMBER: SC710112)

Balance Sheet - continued
31 JANUARY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 June 2024 and were signed by:





S Shafiq - Director


IRVINE HEALTHCARE LTD (REGISTERED NUMBER: SC710112)

Notes to the Financial Statements
FOR THE YEAR ENDED 31 JANUARY 2024

1. STATUTORY INFORMATION

Irvine Healthcare Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis which assumes that the company will continue in operational existence for the foreseeable future. The company's liabilities exceeded its assets by £178,618 at 31 January 2024 (2023 - £102,715). The company is thus dependent on the continued financial support of its creditors. The director is confident of this continuing support and of the company's long term trading prospects and on this basis considers it appropriate to prepare the financial statements on the going concern basis. The financial statements do not include any adjustments that would result from the withdrawal of financial support.

Turnover
Turnover represents the amounts derived from the provision of services which fall within the company's ordinary activities. Revenue is recognised on despatch of services.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 2% on a straight line basis
Plant and machinery - 20% on a reducing balance basis
Fixtures and fittings - 20% on a straight line basis
Computer equipment - 33% on a straight line basis

Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

IRVINE HEALTHCARE LTD (REGISTERED NUMBER: SC710112)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 JANUARY 2024

2. ACCOUNTING POLICIES - continued

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2023 - 6 ) .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 February 2023 29,887 126,052 99,591 11,849 267,379
Additions - 5,500 - - 5,500
At 31 January 2024 29,887 131,552 99,591 11,849 272,879
DEPRECIATION
At 1 February 2023 598 25,211 19,918 3,910 49,637
Charge for year 597 21,268 19,919 3,910 45,694
At 31 January 2024 1,195 46,479 39,837 7,820 95,331
NET BOOK VALUE
At 31 January 2024 28,692 85,073 59,754 4,029 177,548
At 31 January 2023 29,289 100,841 79,673 7,939 217,742

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 16,826 5,127

IRVINE HEALTHCARE LTD (REGISTERED NUMBER: SC710112)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 JANUARY 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 15,013 3,263
Taxation and social security 4,798 -
Other creditors 374,664 323,906
394,475 327,169

7. RELATED PARTY DISCLOSURES

At 31 January 2024, the company owed £370,329 to Companies under common directorship (2023: £322,053).